Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome

ClinicalTrials.gov ID: NCT03721107

Public ClinicalTrials.gov record NCT03721107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety and Efficacy of Repeated Oral Doses of Blautix in Adult Subjects With Irritable Bowel Syndrome (IBS) Subtypes IBS-C and IBS-D

Study identification

NCT ID
NCT03721107
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
4D pharma plc
Industry
Enrollment
366 participants

Conditions and interventions

Interventions

  • Blautix Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2018
Primary completion
May 12, 2020
Completion
May 12, 2020
Last update posted
Jan 10, 2022

2018 – 2020

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Clinical Research Associates Huntsville Alabama 35801
Elite Clinical Studies Phoenix Arizona 85018
Translational Research Group, Inc North Hollywood California 91606
Probe Clinical Research Riverside California 92501
Connecticut Gastroenterology Clinical Research Bristol Connecticut 06010
Digestive CARE of North Broward, LLC Coral Springs Florida 33065
Borland-Groover Clinic Jacksonville Florida 32256
Orlando Florida BioClinica Research Network Orlando Florida 32806
Clinical Research Center of Florida Pompano Beach Florida 33060
East Coast Institute for Research, LLC. Saint Augustine Florida 32086
Guardian Angel Research Center Tampa Florida 33614
Georgia Medical Associates Snellville Georgia 30078
Evanston Premier Healthcare & Research, LLC. Evanston Illinois 60201
Centex Research, Inc. Lake Charles Louisiana 70601
Capitol Research Rockville Maryland 20850
Specialists in Gastroenterology St Louis Missouri 63141
PharmQuest Greensboro North Carolina 27408
Aventiv Research Inc. Columbus Ohio 43213
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
WR-ClinSearch Chattanooga Tennessee 37421
Clinical Neuroscience Solutions, Inc Memphis Tennessee 38119
Houston Methodist Gastroenterology Associates Houston Texas 77030
Gulf Coast Medical Research, LLC. Missouri City Texas 77459
Blue Ridge Medical Research Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03721107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03721107 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →